1. Home
  2. RCKT vs BANR Comparison

RCKT vs BANR Comparison

Compare RCKT & BANR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • BANR
  • Stock Information
  • Founded
  • RCKT 1999
  • BANR 1890
  • Country
  • RCKT United States
  • BANR United States
  • Employees
  • RCKT N/A
  • BANR N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • BANR Major Banks
  • Sector
  • RCKT Health Care
  • BANR Finance
  • Exchange
  • RCKT Nasdaq
  • BANR Nasdaq
  • Market Cap
  • RCKT 1.9B
  • BANR 2.2B
  • IPO Year
  • RCKT N/A
  • BANR 1995
  • Fundamental
  • Price
  • RCKT $16.82
  • BANR $64.25
  • Analyst Decision
  • RCKT Strong Buy
  • BANR Buy
  • Analyst Count
  • RCKT 9
  • BANR 6
  • Target Price
  • RCKT $53.22
  • BANR $61.20
  • AVG Volume (30 Days)
  • RCKT 617.5K
  • BANR 237.0K
  • Earning Date
  • RCKT 11-12-2024
  • BANR 10-16-2024
  • Dividend Yield
  • RCKT N/A
  • BANR 2.99%
  • EPS Growth
  • RCKT N/A
  • BANR N/A
  • EPS
  • RCKT N/A
  • BANR 4.78
  • Revenue
  • RCKT N/A
  • BANR $593,391,000.00
  • Revenue This Year
  • RCKT N/A
  • BANR N/A
  • Revenue Next Year
  • RCKT $382.35
  • BANR $4.01
  • P/E Ratio
  • RCKT N/A
  • BANR $13.46
  • Revenue Growth
  • RCKT N/A
  • BANR N/A
  • 52 Week Low
  • RCKT $15.98
  • BANR $41.87
  • 52 Week High
  • RCKT $32.53
  • BANR $68.11
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 43.54
  • BANR 54.60
  • Support Level
  • RCKT $16.48
  • BANR $63.18
  • Resistance Level
  • RCKT $17.75
  • BANR $66.68
  • Average True Range (ATR)
  • RCKT 0.72
  • BANR 1.67
  • MACD
  • RCKT -0.01
  • BANR -0.27
  • Stochastic Oscillator
  • RCKT 15.93
  • BANR 22.80

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.

About BANR Banner Corporation

Banner Corp is a bank holding company. It wholly owns one subsidiary bank, Banner Bank. The Bank's primary business is that of traditional banking institutions, accepting deposits and originating loans in locations surrounding its offices in Washington, Oregon, California, Idaho and Utah. Banner Bank also actively participates in the secondary loan markets, engaging in mortgage banking operations largely through the origination and sale of one to four family residential loans.

Share on Social Networks: